Zdrowie i gospodarka · 16/08/2018

FDA Requests Public Comment on Proposed Survey of Investigational New Drug Sponsors

The Food and Drug Administration is seeking public input on a proposed survey of sponsors of investigational new drugs to assess their communication practices with FDA review staff, as required by the Paperwork Reduction Act of 1995.